von Minckwitz, Gunter <br/><br/>
Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapy.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jun 2011 
 - 2150-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2010.31.9079  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--analysis<br/>Breast Neoplasms--drug therapy<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Cyclophosphamide--administration & dosage<br/>Cytoplasm--enzymology<br/>Disease-Free Survival<br/>Docetaxel<br/>Doxorubicin--administration & dosage<br/>ErbB Receptors--biosynthesis<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Multicenter Studies as Topic<br/>Neoadjuvant Therapy<br/>Poly(ADP-ribose) Polymerases--metabolism<br/>Prognosis<br/>Randomized Controlled Trials as Topic<br/>Receptors, Estrogen--biosynthesis<br/>Receptors, Progesterone--biosynthesis<br/>Taxoids--administration & dosage<br/>Treatment Outcome